Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration

Fertility and Sterility

Volumn 96, Issue 4, 2011, Pages 898-904

  Propst, Anthony M ^a,b,c   Hill, Micah J ^a   Bates, Gordon Wright ^b   Palumbo, Michelle ^b   Van Horne, Anne K ^b   Retzloff, Matthew G ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

GnRH antagonist; IVF; low dose uhCG; luteinizing hormone

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GANIRELIX; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BIRTH RATE; DRUG WITHDRAWAL; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; EVENING DOSAGE; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LOW DRUG DOSE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MORNING DOSAGE; MULTIPLE CYCLE TREATMENT; NIDATION; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; CHORIONIC GONADOTROPIN; COHORT STUDIES; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; LUTEINIZING HORMONE; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053316829     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.06.069     Document Type: Article

References (69)

1. F. Olivennes, J.S. Cunha-Filho, R. Fanchin, P. Bouchard, and R. Frydman The use of GnRH antagonists in ovarian stimulation Hum Reprod Update 8 2002 279 290 (Pubitemid 34618945)
2. B.C. Tarlatzis, B.C. Fauser, E.M. Kolibianakis, K. Diedrich, P. Devroey Brussels Gn RHAC GnRH antagonists in ovarian stimulation for IVF Hum Reprod Update 12 2006 333 340 (Pubitemid 43932048)
3. G. Griesinger Ovarian hyperstimulation syndrome prevention strategies: use of gonadotropin-releasing hormone antagonists Semin Reprod Med 28 2010 493 499
4. I.J.M. Duijkers, C. Klipping, W.N.P. Willemsen, D. Krone, E. Schneider, and G. Niebch Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers Hum Reprod 13 1998 2392 2398 (Pubitemid 28451211)
5. G. Griesinger, A. Dawson, A. Schultze-Mosgau, D. Finas, K. Diedrich, and R. Felberbaum Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol Fertil Steril 85 2006 791 793 (Pubitemid 43261590)
6. L. Sommer, K. Zanger, T. Dyong, C. Dorn, T. Luckhaus, and K. Diedrich 7-Day administration of the gonadotropin-releasing-hormone antagonist cetrorelix in normal cycling women Eur J Endocrinol 131 1994 280 285 (Pubitemid 24297518)
7. M.A. Esposito, K.T. Barnhart, C. Coutifaris, and P. Patrizio Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone Fertil Steril 75 2001 519 524 (Pubitemid 32175666)
8. L.G. Westergaard, S.B. Laursen, and C.Y. Andersen Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction Hum Reprod 15 2000 1003 1008 (Pubitemid 30251290)
9. D.R. Meldrum, R.T. Scott, M.J. Levy, M.M. Alper, and N. Noyes Oral contraceptive pretreatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients, be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pregnancy loss Fertil Steril 91 2009 1963 1965
10. B. Mannaerts, P. Devroey, T. Abyholm, K. Diedrich, T. Hillensjo, and B. Hedon A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon) Hum Reprod 13 1998 3023 3031 (Pubitemid 28521843)
11. B. Acevedo, M. Sanchez, J.L. Gomez, J. Cuadros, E. Ricciarelli, and E.R. Hernandez Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles Fertil Steril 82 2004 343 347 (Pubitemid 39092033)
12. P. Serafini, I. Yadid, E.L.A. Motta, J.R. Alegretti, J. Fioravanti, and M. Coslovsky Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial Fertil Steril 86 2006 830 838 (Pubitemid 44485029)
13. M. Filicori, G.E. Cognigni, E. Gamberini, L. Parmegiani, E. Troilo, and B. Roset Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation Fertil Steril 84 2005 394 401 (Pubitemid 41125260)
14. A.K. Van Horne, G.W. Bates, R.D. Robinson, N.J. Arthur, and A.M. Propst Recombinant follicle-stimulating hormone (rFSH) supplemented with low-dose human chorionic gonadotropin compared with rFSH alone for ovarian stimulation for in vitro fertilization Fertil Steril 88 2007 1010 1013 (Pubitemid 47498384)
15. K. Koichi, N. Yukiko, K. Shima, and S. Sachiko Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol J Assist Reprod Genet 23 2006 223 228 (Pubitemid 43988389)
16. R. Lahoud, M. Al-Jefout, J. Tyler, J. Ryan, and G. Driscoll A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates Hum Reprod 21 2006 2645 2649 (Pubitemid 44542158)
17. L. O'Dea, F. O'Brien, K. Currie, and G. Hemsey Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect Curr Med Res Opin 24 2008 2785 2793
18. R. Fleming, C.C. Chung, R.W.S. Yates, and J.R.T. Coutts Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity Hum Reprod 11 1996 1854 1858 (Pubitemid 26381426)
19. Z. Shoham The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation Fertil Steril 77 2002 1170 1177 (Pubitemid 34626325)
20. D.C. Schoot, J. Harlin, Z. Shoham, B. Mannaerts, N. Lahlou, and P. Bouchard Recombinant human follicle-stimulating-hormone and ovarian response in gonadotropin-deficient women Hum Reprod 9 1994 1237 1242 (Pubitemid 24223987)
21. Z. Shoham, H. Smith, T. Yeko, F. O'Brien, G. Hemsey, and L. O'Dea Recombinant LH (lutropin alfa) for the treatment of hypogonadotrophic women with profound LH deficiency: a randomized, double-blind, placebo-controlled, proof-of-efficacy study Clin Endocrinol 69 2008 471 478
22. R. Kaufmann, R. Dunn, T. Vaughn, G. Hughes, F. O'Brien, and G. Hemsey Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women Clin Endocrinol 67 2007 563 569 (Pubitemid 47416315)
23. B. Couzinet, N. Lestrat, S. Brailly, M. Forest, and G. Schaison Stimulation of ovarian follicular maturation with pure follicle-stimulating- hormone in women with gonadotropin-deficiency J Clin Endocrinol Metab 66 1988 552 556 (Pubitemid 18076002)
24. W.F. Crowley, and J.W. McArthur simulation of the normal menstrual-cycle in Kallman syndrome by pulsatile administration of luteinizing-hormone-releasing hormone (LHRH) J Clin Endocrinol Metab 51 1980 173 175 (Pubitemid 10009260)
25. European Recombinant Human LHSG Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study J Clin Endocrinol Metab 83 1998 1507 1514
26. Z. Kilani, A. Dakkak, S. Ghunaim, G.E. Cognigni, C. Tabarelli, and L. Parmegiani A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes Hum Reprod 18 2003 1194 1199 (Pubitemid 36740563)
27. A.F. Ismail, A.I. Hesham, Z. Salah, M. Khaled, N. Fouad, and N. Ashraf A prospective comparative study on IVF outcomes with either purified FSH or human menopausal gonadotrophin in downregulated normogonadotrophic women Gynecol Obstet Invest 53 2002 220 223 (Pubitemid 34977923)
28. A.N. Andersen, P. Devroey, J.C. Arce, and M. Grp Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial Hum Reprod 21 2006 3217 3227 (Pubitemid 44811626)
29. E. Bosch, C. Vidal, E. Labarta, C. Simon, J. Remohi, and A. Pellicer Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists - a randomized study Hum Reprod 23 2008 2346 2351
30. E.H.Y. Ng, E.Y.L. Lau, W.S.B. Yeung, and P.C. Ho HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial Hum Reprod 16 2001 319 325 (Pubitemid 32149428)
31. B.H. Rashidi, F. Sarvi, E.S. Tehrani, F. Zayeri, M. Movahedin, and N. Khanafshar The effect of hMG and recombinant human FSH on oocyte quality: a randomized single-blind clinical trial Eur J Obstet Gynecol Reprod Biol 120 2005 190 194 (Pubitemid 40745323)
32. S.C. Chappel, and C. Howles Reevaluation of the roles of luteinizing-hormone and follicle-stimulating-hormone in the ovulatory process Hum Reprod 6 1991 1206 1212
33. B.J. Van Voorhis, M. Thomas, E.S. Surrey, and A. Sparks What do consistently high-performing in vitro fertilization programs in the US do? Fertil Steril 94 2010 1346 1349
34. L.G. Westergaard, K. Erb, S.B. Laursen, S. Rex, and P.E. Rasmussen Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study Fertil Steril 76 2001 543 549
35. P.E. Levi-Setti, M. Cavagna, and C. Bulletti Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: Comparison of r-FSH alone and in combination with r-LH Eur J Obstet Gynecol Reprod Biol 126 2006 212 216 (Pubitemid 43766308)
36. B. Tarlatzis, E. Tavmergen, M. Szamatowicz, A. Barash, A. Amit, and E. Levitas The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study Hum Reprod 21 2006 90 94 (Pubitemid 41794295)
37. G. Griesinger, A. Schultze-Mosgau, K. Dafopoulos, A. Schroeder, A. Schroer, and S. von Otte Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol Hum Reprod 20 2005 1200 1206 (Pubitemid 40790242)
38. F. Lisi, L. Rinaldi, S. Fishel, D. Caserta, R. Lisi, and A. Campbell Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization Fertil Steril 83 2005 309 315 (Pubitemid 40221781)
39. G. De Placido, C. Alviggi, A. Perino, I. Strina, F. Lisi, and A. Fasolino Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH: a multicentre, prospective, randomized controlled trial Hum Reprod 20 2005 390 396 (Pubitemid 40277606)
40. M.V. Sauer, M.H. Thornton, W. Schoolcraft, and G.N. Frishman Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction Reprod Biomed Online 9 2004 487 493 (Pubitemid 39517491)
41. I. Cedrin-Durnerin, D. Grange-Dujardin, A. Laffy, I. Parneix, N. Massin, and J. Galey Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study Hum Reprod 19 2004 1979 1984 (Pubitemid 39242642)
42. I. Ben-Ami, L. Armon, S. Freimann, D. Strassburger, R. Ron-El, and A. Amsterdam EGF-like growth factors as LH mediators in the human corpus luteum Hum Reprod 24 2009 176 184
43. M. Hsieh, A.M. Zamah, and M. Conti Epidermal growth factor-like growth factors in the follicular fluid: role in oocyte development and maturation Semin Reprod Med 27 2009 52 61
44. I. Ben-Ami, A. Komsky, O. Bern, E. Kasterstein, D. Komarovsky, and R. Ron-El In vitro maturation of human germinal vesicle-stage oocytes: role of epidermal growth factor-like growth factors in the culture medium Hum Reprod 26 2011 76 81
45. L.P. Lovely, A.T. Fazleabas, M.A. Fritz, D.G. McAdams, and B.A. Lessey Prevention of endometrial apoptosis: Randomized prospective comparison of human chorionic gonadotropin versus progesterone treatment in the luteal phase J Clin Endocrinol Metab 90 2005 2351 2356 (Pubitemid 40586284)
46. A. Jasinska, Z. Strakova, M. Szmidt, and A.T. Fazleabas Human chorionic gonadotropin and decidualization in vitro inhibits cytochalasin-D-induced apoptosis in cultured endometrial stromal fibroblasts Endocrinology 147 2006 4112 4121 (Pubitemid 44268364)
47. A. Jurisicova, M. Antenos, K. Kapasi, J. Meriano, and R.F. Casper Variability in the expression of trophectodermal markers beta-human chorionic gonadotrophin, human leukocyte antigen-G and pregnancy specific beta-1 glycoprotein by the human blastocyst Hum Reprod 14 1999 1852 1858 (Pubitemid 29358713)
48. M.L. Bonduelle, R. Dodd, I. Liebaers, A. Vansteirteghem, R. Williamson, and R. Akhurst Chorionic gonadotrophin-beta messenger-RNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes Hum Reprod 3 1988 909 914
49. A. Lopata, and D.L. Hay The surplus human-embryo - its potential for growth, blastulation, hatching, and human chorionic-gonadotropin production in culture Fertil Steril 51 1989 984 991 (Pubitemid 19156903)
50. M. Filicori, A.T. Fazleabas, I. Huhtaniemi, P. Licht, C.V. Rao, and J. Tesarik Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility Fertil Steril 84 2005 275 284 (Pubitemid 41125241)
51. S.W. Han, Z.M. Lei, and C.V. Rao Treatment of human endometrial stromal cells with chorionic gonadotropin promotes their morphological and functional differentiation into decidua Mol Cell Endocrinol 147 1999 7 16 (Pubitemid 29090388)
52. P. Cameo, M. Szmidt, Z. Strakova, P. Mavrogianis, K.L. Sharpe-Timms, and A.T. Fazleabas Decidualization regulates the expression of the endometrial chorionic gonadotropin receptor in the primate Biol Reprod 75 2006 681 689 (Pubitemid 44720387)
53. S.P. d'Hauterive, S. Berndt, M. Tsampalas, C. Charlet-Ranaud, M. Dubois, and C. Bourgain Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation? Gynecol Obstet Invest 64 2007 156 160 (Pubitemid 47574875)
54. U.D. Gordon, R.F. Harrison, M. Fawzy, B. Hennelly, and A.C. Gordon A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome Fertil Steril 75 2001 324 331 (Pubitemid 32112109)
55. R. Matorras, B. Prieto, A. Exposito, R. Mendoza, L. Crisol, and P. Herranz Mid-follicular LH supplementation in women 35-39 years undergoing ICSI cycles: a randomized controlled study Reprod Biomed Online 19 2009 879 887
56. F. Fabregues, M. Creus, J. Penarrubia, D. Manau, J.A. Vanrell, and J. Balasch Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age Fertil Steril 85 2006 925 931
57. P.G.A. Hompes, F.J. Broekmans, D.A. Hoozemans, R. Schats, and F. Grp Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization- intracytoplasmic sperm injection patients Fertil Steril 89 2008 1685 1693 (Pubitemid 351756496)
58. E. Bosch, E. Labarta, J. Crespo, C. Simón, J. Remohí, and A. Pellicer Impact of luteinizing hormone administration on gonadotropin- releasing hormone antagonist cycles: an age-adjusted analysis Fertil Steril 95 2011 1031 1036
59. M. Filicori, G.E. Cognigni, P. Pocognoli, W. Ciampaglia, and S. Bernardi Current concepts and novel applications of LH activity in ovarian stimulation Trends Endocrinol Metab 14 2003 267 273 (Pubitemid 36988440)
60. M. Filicori, G.E. Cognigni, C. Tabarelli, P. Pocognoli, S. Taraborrelli, and D. Spettoli Stimulation and growth of antral ovarian follicles by selective LH activity administration in women J Clin Endocrinol Metab 87 2002 1156 1161 (Pubitemid 36121081)
61. M. Filicori, G.E. Cognigni, A. Samara, S. Melappioni, T. Perri, and B. Cantelli The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction Hum Reprod Update 8 2002 543 557 (Pubitemid 35452780)
62. R. Baruffi, A.L. Mauri, C. Petersen, V. Felipe, A. Martins, and J. Cornicelli Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis Reprod Biomed Online 14 2007 14 25 (Pubitemid 46156558)
63. M.K.O. Gomes, C.S. Vieira, M.D. Moura, L.A. Manetta, S.P. Leite, and R.M. Reis Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG Eur J Obstet Gynecol Reprod Biol 130 2007 99 106 (Pubitemid 44920443)
64. H.G. Al-Inany, A.M. Abou-Setta, M.A. Aboulghar, R.T. Mansour, and G.I. Serour Efficacy and safety of human menopausal gonadotrophins versus meta-analysis recombinant FSH: a mate-analysis Reprod Biomed Online 16 2008 81 88 (Pubitemid 351187376)
65. A. Coomarasamy, M. Afnan, D. Cheema, F. van der Veen, P.M.M. Bossuyt, and M. van Wely Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis Hum Reprod 23 2008 310 315 (Pubitemid 351651234)
66. K. Doody, P. Devroey, K. Gordon, H. Witjes, and B. Mannaerts LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles Reprod Biomed Online 20 2010 565 567
67. P. Merviel, J.-M. Antoine, E. Mathieu, F. Millot, J. Mandelbaum, and S. Uzan Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer Fertil Steril 82 2004 119 125 (Pubitemid 38968786)
68. T. Jaakkola, Y.Q. Ding, P. Kellokumpulehtinen, R. Valavaara, H. Martikainen, and J. Tapanainen The ratios of serum bioactive immunoreactive luteinizing-hormone and follicle-stimulating-hormone in various clinical conditions with increased and decreased gonadotropin-secretion - reevaluation by a highly sensitive immunometric assay J Clin Endocrinol Metab 70 1990 1496 1505
69. I.P. Kosmas, K. Zikopoulos, I. Georgiou, E. Paraskevaidis, C. Blockeel, and H. Tournaye Low-dose HCG may improve pregnancy rates and lower OHSS in antagonist cycles: a meta-analysis Reprod Biomed Online 19 2009 619 630